TABLE 4.
The association of adolescent anxiety severity (GAD‐7 total score) with adolescent demographical characteristics, clinical characteristics, adolescent diabetes‐specific distress, and parental distress (n = 147)
| Step 1 B (95% BCa) | Step 2 B (95% BCa) | Step 3 B (95% BCa) | Step 4 B (95% BCa) | ||
|---|---|---|---|---|---|
| Demographic characteristics | Age adolescent (years) | 0.21 (0.03–0.40)* | 0.26 (0.04–0.47)* | 0.10 (−0.10 to 0.29) | 0.09 (−0.10 to 0.27) |
| Female sex adolescent | 1.29 (0.47–2.19)** | 1.25 (0.43–2.09)** | 0.41 (−0.25 to 1.15) | 0.39 (−0.30 to 1.12) | |
| Clinical characteristics | Diabetes duration (years) | −0.08 (−0.20 to 0.04) | −0.08 (−0.20 to 0.03) | −0.08 (−0.19 to 0.03) | |
| Insulin treatment modality, CSII | −1.01 (−2.32 to 0.24) | −0.91 (−2.02 to 0.22) | −0.99 (−2.10 to 0.08) | ||
| Most recent HbA1c (mmol/mol) | 0.01 (−0.02 to 0.04) | −0.01 (−0.04 to 0.02) | −0.01 (−0.04 to 0.02) | ||
| Adolescent diabetes distress | Diabetes distress (PAID‐T) | 0.07 (0.05–0.09)** | 0.07 (0.05–0.09)** | ||
| Parental distress | Anxiety symptoms (GAD‐7) | −0.07 (−0.30 to 0.13) | |||
| Depressive symptoms (PHQ‐9) | 0.12 (−0.09 to 0.34) | ||||
| Diabetes distress (PAID‐PR) | −0.01 (−0.05 to 0.02) | ||||
| Adjusted R 2 | 0.07** | 0.09** | 0.27** | 0.27** | |
| R 2 change | 0.08** | 0.04 | 0.18** | 0.01 |
Note: Reported are the bootstrapped unstandardized regression coefficients and the 95% bias corrected accelerated confidence interval, and the proportion of explained variance. Results from post‐hoc analyses were not included in this table. Sex adolescent was binary coded as boy = 0 versus girl = 1; insulin treatment modality as multiple daily self‐injections = 0 versus continuous subcutaneous insulin infusion = 1. Adjusted R 2 reported the fit of the regression model adjusted for the number of predictor variables. R 2 change signified whether each hierarchical block significantly improved the fit of the regression model.
p < 0.05;
p < 0.01; ***p < 0.001.